Key result
A 36-year-old male kidney transplant recipient on immunosuppressive therapy developed a rare angiosarcoma from a nonfunctioning arteriovenous fistula.
Why the study?
Angiosarcoma can occasionally arise as a complication of arteriovenous fistulas, but remains an uncommon disease requiring further documentation of its clinical manifestations and management strategies.
Case Report (n=1)
Angiosarcoma can rarely develop as a complication of a nonfunctioning arteriovenous fistula in immunosuppressed post-kidney transplant patients.
Alerts clinicians to rare angiosarcoma in nonfunctioning AV fistulas post-transplant; hypothesis-generating and should not change practice.
Angiosarcoma is a rare and aggressive malignant neoplasm that originates from the endothelial cells lining blood vessels. It can occasionally arise as a complication of both functional and nonfunctional arteriovenous fistulas. This paper will present a documented case of angiosarcoma developing from a nonfunctioning fistula in a 36-year-old male who underwent kidney transplantation and was on immunosuppressive therapies. The clinical manifestations, management strategies, and a comprehensive review of the literature on this uncommon disease will be discussed.
No takes yet. Share an insight, caveat, or question.
Salloum et al. (2025) conducted a case report in Angiosarcoma developing from a nonfunctioning arteriovenous fistula (n=1). Nonfunctioning arteriovenous fistula and immunosuppressive therapies was evaluated on Development of angiosarcoma. A 36-year-old male kidney transplant recipient on immunosuppressive therapy developed a rare angiosarcoma from a nonfunctioning arteriovenous fistula.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: